PDA

View Full Version : Multiple modes of action of eribulin mesylate: Emerging data and clinical implication


Nguyen
08-24-2019, 01:45 PM
https://www.cancertreatmentreviews.com/article/S0305-7372(18)30143-9/fulltext

Some key points in this article: Aside from its antimitotic activity, Eribulin (Halaven) enables better absorption of another drug after it, possible reverse endocrine resistance (so looking forward to this to be true), causes tumor to become less invasive and aggressive, suitable for metronomic method.

Nguyen